| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |